Clear licensing terms ensuring open access to stem cell research while protecting author rights.
Open Access Licensing
Journal of Evolving Stem Cell Research publishes all articles under Creative Commons licensing, ensuring maximum accessibility and reuse of regenerative medicine research while maintaining appropriate author protections.
Our licensing framework balances open science principles with recognition of author contributions to stem cell advancement and therapeutic development.
All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This widely-adopted license enables broad use of stem cell research while requiring proper attribution to original authors.
Sharing Rights
Anyone may copy and redistribute stem cell research in any medium or format for any purpose, including commercial applications, with proper attribution.
Adaptation Rights
Regenerative medicine research may be transformed, remixed, or built upon for any purpose. Derivatives must credit the original work.
Attribution Requirement
Users must give appropriate credit, provide a license link, and indicate if content was modified when reusing published stem cell work.
No Additional Restrictions
Licensors cannot impose additional legal terms or technological measures that restrict others from exercising permitted uses.
Authors publishing in Journal of Evolving Stem Cell Research retain significant rights to their research work. Understanding these rights helps authors maximize the value of their regenerative medicine publications.
- Copyright remains with the author(s), not transferred to the journal for stem cell publications
- Authors may reuse their content in subsequent publications with proper citation
- Educational use of your own material for training requires no additional permission
- Inclusion in edited collections or textbooks is permitted with attribution
- Commercial reuse rights are retained under the CC BY license
Funder compliance: CC BY 4.0 licensing satisfies open access requirements from major research funders including NIH, CIRM, and similar organizations supporting stem cell research and regenerative medicine development.
Authors must ensure they have rights to publish all content included in stem cell manuscripts. Third-party images, figures, or cell line images require appropriate permissions and institutional agreements.
For questions about licensing terms, reuse permissions, or specific situations not addressed here, contact the editorial office. We provide guidance helping authors and users understand rights and responsibilities for stem cell content.
Publish Open Access
Share your stem cell research with the world under clear, permissive licensing terms.
Submit ResearchCC BY licensing satisfies open access requirements from major research funders including NIH, Wellcome Trust, UKRI, and European Commission frameworks. Authors funded by organizations mandating immediate open access can publish with confidence that licensing terms meet funder requirements. Contact the editorial office with licensing questions.
Authors may freely distribute published work through repositories and networks.
These policies support researchers in sharing stem cell discoveries globally.
Contact the editorial office with licensing questions.
Contact us today.
Public Access and Funder Compliance
Some authors are required by their funders to make their research publicly available. Under the 2024 NIH Public Access Policy, Author Accepted Manuscripts accepted for publication on or after July 1, 2025, must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official date of publication.
What JESR provides: JESR publishes the Version of Record under the Creative Commons Attribution 4.0 International licence. The journal also permits authors to deposit their Author Accepted Manuscript in funder-designated repositories. Upon acceptance, we confirm the accepted manuscript version and record the funder and grant information supplied by the authors.
Author responsibility: JESR does not currently deposit manuscripts in PubMed Central on behalf of authors. Authors are responsible for determining which funder requirements apply, initiating the appropriate repository submission and completing any required NIHMS approval steps.
Eligibility and successful processing through PubMed Central or NIHMS are determined according to the relevant funder and NIH/NLM requirements.
Important: The deposit of an individual article in PubMed Central may result in that article appearing in PubMed. It does not mean that JESR is indexed in MEDLINE, included in the PMC Journal List or that all JESR articles are available through PubMed. The journal's current coverage is listed on the Indexing page.